Ascent Biomedical Ventures
16
16M
12
3
0.25
6
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the New York. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Ascent Biomedical Ventures, startups are often financed by Ventech, Novartis Venture Fund, MP Healthcare Venture Management. The meaningful sponsors for the fund in investment in the same round are Scottish Widows Investment Partnership, Prism Venture Management, MVM Life Science Partners. In the next rounds fund is usually obtained by Scottish Widows Investment Partnership, Scale Venture Partners, SV Health Investors.
Among the most popular portfolio startups of the fund, we may highlight Covagen, Entigo, eCaring. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The top amount of exits for fund were in 2014. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Ascent Biomedical Ventures works on 2 percentage points more the average amount of lead investments.
This organization was formed by Geoffrey W. Smith. Besides them, we counted 4 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 3
- Exits
- 6
- Follow on index
- 0.25
- Investments by industry
- Health Care (12)
- Biotechnology (9)
- Therapeutics (6)
- Medical (4)
- Wellness (2) Show 14 more
- Investments by region
-
- United States (14)
- Switzerland (1)
- Israel (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 15M
- Group Appearance index
- 0.81
- Avg. company exit year
- 12
- Avg. multiplicator
- 0.74
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Cara Therapeutics | 28 Nov 2006 | Biotechnology, Health Care, Therapeutics | Late Stage Venture | 24M | United States, Connecticut |
01 May 2015 | Health Care, Hospital, Medical | Seed | 3M | United States, California, Santa Clara |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.